WISP1 (CCN4) Autoregulates Its Expression and Nuclear Trafficking of β-catenin During Oxidant Stress with Limited Effects Upon Neuronal Autophagy

Overview

Journal Curr Neurovasc Res

Publisher Bentham Science Publishers

Specialties Cardiology & Vascular Diseases
Neurology

Date 2012 Apr 6

PMID 22475393

Citations 44

Authors

Shaohui Wang

Zhao Zhong Chong

Yan Chen Shang

Kenneth Maiese

Affiliations

Soon will be listed here.

Abstract

Wnt1 inducible signaling pathway protein 1 (WISP1/CCN4) is a CCN family member more broadly identified with development and tumorigenesis. However, recent studies have shed new light and enthusiasm on WISP1 as a novel target directed against toxic cell degeneration. Here we show WISP1 prevents apoptotic degeneration in primary neurons during oxidant stress through the activation of protein kinase B (Akt1), the post-translational maintenance of β-catenin integrity that is consistent with inhibition of glycogen synthase kinase-3β (GSK-3β), and the subcellular trafficking of β- catenin to foster its translocation to the nucleus. Interestingly, WISP1 autoregulates its expression through the promotion of β-catenin activity and may employ β-catenin to have a limited control over autophagy, but neuronal injury during oxidant stress as a result of autophagy appears portioned to a small population of neurons without significant impact upon overall cell survival. New strategies that target WISP1, its autoregulation, and the pathways responsible for neuronal cell injury may bring forth new insight for the treatment of neurodegenerative disorders.

Citing Articles

WISP1 and Macrophage Migration Inhibitory Factor in Respiratory Inflammation: Novel Insights and Therapeutic Potentials for Asthma and COPD.

Christopoulou M, Aletras A, Papakonstantinou E, Stolz D, Skandalis S Int J Mol Sci. 2024; 25(18).

PMID: 39337534 PMC: 11432718. DOI: 10.3390/ijms251810049.

An overview of CCN4 (WISP1) role in human diseases.

Singh K, Oladipupo S J Transl Med. 2024; 22(1):601.

PMID: 38937782 PMC: 11212430. DOI: 10.1186/s12967-024-05364-8.

The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk.

Maiese K Front Immunol. 2023; 14:1273570.

PMID: 38022638 PMC: 10663950. DOI: 10.3389/fimmu.2023.1273570.

Cornerstone Cellular Pathways for Metabolic Disorders and Diabetes Mellitus: Non-Coding RNAs, Wnt Signaling, and AMPK.

Maiese K Cells. 2023; 12(22).

PMID: 37998330 PMC: 10670256. DOI: 10.3390/cells12222595.

The non-invasive diagnosis of colorectal cancer via a SOX9-based gene panel.

Xue V, Ng S, Tsang H, Wong H, Leung W, Wong Y Clin Exp Med. 2023; 23(6):2421-2432.

PMID: 36637582 DOI: 10.1007/s10238-022-00970-6.

References

Shahjee H, Koch K, Guo L, Zhang C, Keay S . Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells. J Exp Clin Cancer Res. 2010; 29:160. PMC: 3020166. DOI: 10.1186/1756-9966-29-160. View

Chong Z, Kang J, Li F, Maiese K . mGluRI targets microglial activation and selectively prevents neuronal cell engulfment through Akt and caspase dependent pathways. Curr Neurovasc Res. 2005; 2(3):197-211. PMC: 1986675. DOI: 10.2174/1567202054368317. View

Chong Z, Maiese K . Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-3-3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrity. Br J Pharmacol. 2007; 150(7):839-50. PMC: 1952181. DOI: 10.1038/sj.bjp.0707161. View

Koh S, Noh M, Cho G, Kim K, Kim S . Erythropoietin increases the motility of human bone marrow-multipotent stromal cells (hBM-MSCs) and enhances the production of neurotrophic factors from hBM-MSCs. Stem Cells Dev. 2008; 18(3):411-21. DOI: 10.1089/scd.2008.0040. View

Chong Z, Li F, Maiese K . Group I metabotropic receptor neuroprotection requires Akt and its substrates that govern FOXO3a, Bim, and beta-catenin during oxidative stress. Curr Neurovasc Res. 2006; 3(2):107-17. PMC: 2040240. DOI: 10.2174/156720206776875830. View

Chong Z, Kang J, Maiese K . Apaf-1, Bcl-xL, cytochrome c, and caspase-9 form the critical elements for cerebral vascular protection by erythropoietin. J Cereb Blood Flow Metab. 2003; 23(3):320-30. DOI: 10.1097/01.WCB.0000050061.57184.AE. View

Hou J, Wang S, Shang Y, Chong Z, Maiese K . Erythropoietin employs cell longevity pathways of SIRT1 to foster endothelial vascular integrity during oxidant stress. Curr Neurovasc Res. 2011; 8(3):220-35. PMC: 3149772. DOI: 10.2174/156720211796558069. View

Zeng K, Wang X, Ko H, Kwon H, Cha J, Yang H . Hyperoside protects primary rat cortical neurons from neurotoxicity induced by amyloid β-protein via the PI3K/Akt/Bad/Bcl(XL)-regulated mitochondrial apoptotic pathway. Eur J Pharmacol. 2011; 672(1-3):45-55. DOI: 10.1016/j.ejphar.2011.09.177. View

Case N, Ma M, Sen B, Xie Z, Gross T, Rubin J . Beta-catenin levels influence rapid mechanical responses in osteoblasts. J Biol Chem. 2008; 283(43):29196-205. PMC: 2570859. DOI: 10.1074/jbc.M801907200. View

10.

Toku A, Durmus Tekir S, Ozbayraktar F, Ulgen K . Reconstruction and crosstalk of protein-protein interaction networks of Wnt and Hedgehog signaling in Drosophila melanogaster. Comput Biol Chem. 2011; 35(5):282-92. DOI: 10.1016/j.compbiolchem.2011.07.002. View

11.

Chong Z, Li F, Maiese K . The pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3beta and nuclear factor-kappaB to foster endogenous microglial cell protection. Int J Mol Med. 2007; 19(2):263-72. PMC: 1986680. View

12.

Al Sweidi S, Sanchez M, Bourque M, Morissette M, Dluzen D, Di Paolo T . Oestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in Parkinson's disease. J Neuroendocrinol. 2011; 24(1):48-61. DOI: 10.1111/j.1365-2826.2011.02193.x. View

13.

LEpiscopo F, Tirolo C, Testa N, Caniglia S, Morale M, Cossetti C . Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Neurobiol Dis. 2010; 41(2):508-27. PMC: 3558878. DOI: 10.1016/j.nbd.2010.10.023. View

14.

Li F, Chong Z, Maiese K . Microglial integrity is maintained by erythropoietin through integration of Akt and its substrates of glycogen synthase kinase-3beta, beta-catenin, and nuclear factor-kappaB. Curr Neurovasc Res. 2006; 3(3):187-201. PMC: 1986678. DOI: 10.2174/156720206778018758. View

15.

Maiese K, Chong Z, Shang Y . Mechanistic insights into diabetes mellitus and oxidative stress. Curr Med Chem. 2007; 14(16):1729-38. PMC: 2447161. DOI: 10.2174/092986707781058968. View

16.

Baryawno N, Sveinbjornsson B, Eksborg S, Chen C, Kogner P, Johnsen J . Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth. Cancer Res. 2009; 70(1):266-76. DOI: 10.1158/0008-5472.CAN-09-0578. View

17.

Wymann M, Zvelebil M, Pirola L, Vanhaesebroeck B, Waterfield M, Panayotou G . Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol Cell Biol. 1996; 16(4):1722-33. PMC: 231159. DOI: 10.1128/MCB.16.4.1722. View

18.

Shang Y, Chong Z, Wang S, Maiese K . Erythropoietin and Wnt1 govern pathways of mTOR, Apaf-1, and XIAP in inflammatory microglia. Curr Neurovasc Res. 2011; 8(4):270-85. PMC: 3254854. DOI: 10.2174/156720211798120990. View

19.

Su F, Overholtzer M, Besser D, Levine A . WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. Genes Dev. 2002; 16(1):46-57. PMC: 155313. DOI: 10.1101/gad.942902. View

20.

Lin S, Vincent A, Shaw T, Maynard K, Maiese K . Prevention of nitric oxide-induced neuronal injury through the modulation of independent pathways of programmed cell death. J Cereb Blood Flow Metab. 2000; 20(9):1380-91. DOI: 10.1097/00004647-200009000-00013. View